[Research trends on botulinum toxin A in bruxism: a bibliometric analysis]. [PDF]
Rev Med Inst Mex Seguro SocVargas-Echeverría SL +2 more
europepmc +1 more source
[The indirect costs of tension type headache. A systematic literature review]. [PDF]
Aten Primaria, 2022 Del Llano Señarís JE +4 more
europepmc +1 more source
Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]
BiomedicaPanesso GA +7 more
europepmc +1 more source
[Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic]. [PDF]
Rev Gastroenterol Mex, 2022 Manzano-Aquiahuatl C +12 more
europepmc +1 more source
[Successful Management of Wearing-off effect with Eptinezumab: Lessons from a case with Chronic Migraine Refractory to Two Subcutaneous CGRP Antibodies]. [PDF]
Rev NeurolPolanco Fernández M +4 more
europepmc +1 more source
[Simple gastroschisis complicated by multiple perforations, frozen abdomen, and loss of abdominal domain]. [PDF]
An Sist Sanit NavarCayetano Cabrera D +5 more
europepmc +1 more source
Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice. [PDF]
Aesthet Surg J, 2023 Fabi SG, Park JY, Goldie K, Wu W.
europepmc +1 more source
[CefaleApp: A Mobile Application for Migraine Diagnosis in Primary Health Care]. [PDF]
Rev NeurolGarcía-Estévez DA +2 more
europepmc +1 more source
Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab. [PDF]
Rev NeurolGarcía-Estévez DA +5 more
europepmc +1 more source
[Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group]. [PDF]
Neurologia, 2020 Morollón N +6 more
europepmc +1 more source